Rare Disease Trial, Recruiting (NCT06926127)

Rare Disease Trial, Recruiting NCT06926127 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06926127 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Anyone between the ages of 0 and 90 years old
People who a specialist doctor suspects may have a rare or genetic disease, based on their symptoms or test results (for example, features that match a known genetic syndrome, a muscle or nerve condition, or a heart condition like hypertrophic or dilated cardiomyopathy), and who need genetic testing
People whose symptoms suggest they may have a rare or genetic disease, even if it doesn't clearly match any specific known condition
People who are suspected of having a rare or genetic disease and have already had genetic tests done, but those tests came back with no clear result
People who have already been given a genetic diagnosis and could benefit from further questions being answered, such as finding a more personalised prevention or treatment plan

Who may not be able to join:

People (including patients, parents, or legal guardians) who do not wish to take part in the trial for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giovanni Scambia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630155701

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06926127

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: +390630155701

More information: https://clinicaltrials.gov/study/NCT06926127

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Anyone between the ages of 0 and 90 years old
People who a specialist doctor suspects may have a rare or genetic disease, based on their symptoms or test results (for example, features that match a known genetic syndrome, a muscle or nerve condition, or a heart condition like hypertrophic or dilated cardiomyopathy), and who need genetic testing
People whose symptoms suggest they may have a rare or genetic disease, even if it doesn't clearly match any specific known condition
People who are suspected of having a rare or genetic disease and have already had genetic tests done, but those tests came back with no clear result
People who have already been given a genetic diagnosis and could benefit from further questions being answered, such as finding a more personalised prevention or treatment plan

Who may not be able to join:

People (including patients, parents, or legal guardians) who do not wish to take part in the trial for any reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

5 November 2024

Est. completion

30 April 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Reduce diagnostic timelapse of rare genetic conditions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov